Accelerated hyperfractionated radiotherapy with concurrent chemotherapy in locally advanced nasopharyngeal carcinoma: A phase II study

Journal of Cancer Research and Clinical Oncology

Volumn 127, Issue 8, 2001, Pages 507-511

  Fischer, Markus ^a   Stüben, Georg ^a   Klahold, Mareen ^a   Stuschke, Martin ^a   Budach, Volker ^b   Sack, Horst ^a   Jahnke, Klaus ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Accelerated hyperfractionated radiotherapy; Concurrent chemotherapy; Nasopharyngeal carcinoma

Indexed keywords

FLUOROURACIL; FOLINIC ACID; MITOMYCIN C;

ARTICLE; BLINDNESS; BRAIN NECROSIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; NASOPHARYNX CARCINOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; SALVAGE THERAPY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; MITOMYCIN; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034920267     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320100242     Document Type: Article

References (30)

1. Distant metastases of nasopharyngeal carcinoma: A study of 256 male patients
2. Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: A radiation therapy oncology group study
3. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099
4. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma
5. Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally advanced nasopharyngeal and paranasal sinus tumors
6. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
7. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma
8. Accelerated fractionation radiotherapy and concomitant chemotherapy in patients with stage IV inoperable head and neck cancer
9. Combined radiotherapy and chemotherapy in stage T3 and T4 nasopharyngeal carcinoma in children
10. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: Results of a matched cohort study
11. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival
12. Non-parametric estimation from incomplete observations
13. Recurrence patterns with concurrent platinum-based chemotherapy and accelerated hyper-fractionated radiotherapy in stage III and IV head and neck cancer patients
14. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: Overall survival and patterns of failure
15. Caution on the use of altered fractionation for nasopharyngeal carcinoma
16. Partially hyperfractionated accelerated radiotherapy and concurrent chemotherapy for advanced nasopharyngeal carcinoma
17. Radiation therapy alone or in combination with surgery in head and neck cancer
18. Treatment of advanced head and neck cancer with concomitant radiation and chemotherapy
19. Hyperfractionated-accelerated simultaneous radiochemotherapy of advanced hypopharyngeal carcinomas: Survival rates, functional results and quality of life in a phase II study
20. Combined treatment in carcinoma of the nasopharynx
21. Illustrated guide to the TNM/pTNM classification of malignant tumours
22. Accelerated hyperfractionated radiotherapy and simultaneous chemotherapy for locally advanced carcinomas of the pharynx and the floor of the mouth
23. Fractionation sensitivities and dose-control relations of head and neck carcinomas: Analysis of the randomized hyperfractionation trials
24. Sequential chemotherapy and radiation for nasopharyngeal cancer: Absence of long-term benefit despite a high rate of tumor response to chemotherapy
25. Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma
26. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy
27. Hyperfractionated radiotherapy followed by adjuvant chemotherapy for nasopharyngeal cancer: Report of seven cases